- Article
- Source: Campus Sanofi
- 23 Oct 2023
Benefits of switching to Toujeo (insulin glargine 300 Units/mL) through patient case studies and patient reported outcomes
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/iStock-1127105013.jpg/jcr:content/iStock-1127105013.jpg)
Ask us your questions about our products, patient materials or organising a meeting.
T1 Case Studies
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/Pursuing-glycaemic-control-in-type-1-diabetes--10-.jpg/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10).jpg)
A Young Patient with Deteriorating Glycaemic Control
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--10---1-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10)%20(1).png)
Wide Glycaemic Variability
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--13-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(13).png)
Wide Glycaemic Variability with Frequent Hypoglycaemia in a Young Patient
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--10---2-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10)%20(2).png)
Poor Glucose Control in a Young Patient with Comorbid Depression
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--11-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(11).png)
Wide glycaemic variability
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--10---3-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10)%20(3).png)
Hypoglycaemia with severe nocturnal hypoglycaemic episodes
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--10---4-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10)%20(4).png)
A young patient with poor glucose management and disordered eating behaviour
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--10---5-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10)%20(5).png)
Nocturnal hypoglycaemia and the somogyi phenomenon
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/Pursuing-glycaemic-control-in-type-1-diabetes--10-.jpg/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10).jpg)
A Young Patient with Deteriorating Glycaemic Control
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--10---1-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10)%20(1).png)
Wide Glycaemic Variability
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--13-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(13).png)
Wide Glycaemic Variability with Frequent Hypoglycaemia in a Young Patient
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--10---2-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10)%20(2).png)
Poor Glucose Control in a Young Patient with Comorbid Depression
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--11-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(11).png)
Wide glycaemic variability
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--10---3-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10)%20(3).png)
Hypoglycaemia with severe nocturnal hypoglycaemic episodes
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--10---4-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10)%20(4).png)
A young patient with poor glucose management and disordered eating behaviour
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/benefits-of-switching/Image/Pursuing-glycaemic-control-in-type-1-diabetes--10---5-.png/jcr:content/Pursuing%20glycaemic%20control%20in%20type%201%20diabetes%20(10)%20(5).png)
Nocturnal hypoglycaemia and the somogyi phenomenon
T2 Case Studies
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/t2---glycaemic-control.png/jcr:content/t2%20-%20glycaemic%20control.png)
Apparent Glycemic Control
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/t2---pooly-controlled.png/jcr:content/t2%20-%20pooly%20controlled.png)
Patient with Poorly Controlled T2DM
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/t2---elderly-patient.png/jcr:content/t2%20-%20elderly%20patient.png)
Elderly Patient with T2DM
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/t2---glycaemic-variability.png/jcr:content/t2%20-%20glycaemic%20variability.png)
Glycemic Variability and Nocturnal Hypoglycemia
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/t2---glycaemic-control.png/jcr:content/t2%20-%20glycaemic%20control.png)
Apparent Glycemic Control
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/t2---pooly-controlled.png/jcr:content/t2%20-%20pooly%20controlled.png)
Patient with Poorly Controlled T2DM
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/t2---elderly-patient.png/jcr:content/t2%20-%20elderly%20patient.png)
Elderly Patient with T2DM
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/t2---glycaemic-variability.png/jcr:content/t2%20-%20glycaemic%20variability.png)
Glycemic Variability and Nocturnal Hypoglycemia
Hypoglycaemia is the most frequent adverse reaction observed in clinical trials conducted with Toujeo®.7 Other common adverse effects are lipohypertrophy and injection site reactions.7
For further information on the safety profile of Toujeo® please consult the Summary of Product Characteristics >
Diabetes Products
References
1. Colin IM, et al. Diabetes Ther. 2020;11:1835–1847
7. Toujeo Summary of Product Characteristics
MAT-XU-2302861 (v5.0) Date of Preparation: October 2023